EDGAR Filing Documents for 0001358403-17-000154

Form 8-K - Current report:

SEC Accession No. 0001358403-17-000154

Filing Date

2017-08-15

Accepted

2017-08-15 16:17:13

Documents

Period of Report

2017-08-09

Items

Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a8-kcpritgrant.htm	8-K	33564
	Complete submission text file	0001358403-17-000154.txt		34741

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030

Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100

BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 171034101
SIC: 2834 Pharmaceutical Preparations